scanX
Home
Nectar Lifesciences

Nectar Lifesciences

38.98
+0.76
(1.99%)
Market Cap
874.17
EPS
-
PE Ratio (TTM)
78.67
Dividend Yield
0.00
Industry
Healthcare
52 Week High
56.50
52 Week low
26.15
PB Ratio
0.79
Debt to Equity
0.65
Sector
Pharmaceuticals
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
8.42 %
Net Income Growth
-120.66 %
Cash Flow Change
68.12 %
ROE
-120.70 %
ROCE
202.45 %
EBITDA Margin (Avg.)
59.28 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
1,664
1,682
1,666
1,882
2,789
2,371
1,547
1,680
1,567
1,699
1,682
Expenses
1,377
1,437
1,419
1,640
2,519
2,147
1,434
1,510
1,471
1,533
1,507
EBITDA
287
245
247
242
270
224
113
170
96
166
175
Operating Profit %
16 %
14 %
14 %
13 %
9 %
9 %
7 %
10 %
3 %
9 %
10 %
Depreciation
77
57
62
64
63
61
60
57
59
61
61
Interest
126
123
117
115
148
126
112
79
80
87
89
Profit Before Tax
85
64
67
63
59
38
-85
34
-42
18
27
Tax
19
10
12
10
11
6
-12
9
-18
13
17
Net Profit
66
54
55
52
48
32
-73
25
-24
5
11
EPS in ₹
2.95
2.42
2.47
2.33
2.12
1.42
-3.27
1.12
-1.08
0.22
0.50
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
2,511
2,556
2,581
2,724
2,705
2,633
2,388
2,391
2,189
2,191
Fixed Assets
934
906
881
852
825
785
772
723
662
643
Current Assets
1,369
1,464
1,496
1,661
1,669
1,615
1,239
1,355
1,231
1,284
Capital Work in Progress
91
99
102
100
100
115
99
85
78
66
Investments
0
1
1
1
1
0
1
1
1
1
Other Assets
1,485
1,551
1,597
1,771
1,780
1,733
1,517
1,582
1,449
1,482
Total Liabilities
2,511
2,556
2,581
2,724
2,705
2,633
2,388
2,391
2,189
2,191
Current Liabilities
1,156
1,240
1,279
1,309
1,300
1,248
1,187
1,004
891
973
Non Current Liabilities
397
362
296
356
300
249
139
299
234
149
Total Equity
958
954
1,007
1,059
1,105
1,136
1,062
1,088
1,065
1,069
Reserve & Surplus
936
932
984
1,036
1,083
1,114
1,040
1,066
1,042
1,047
Share Capital
22
22
22
22
22
22
22
22
22
22
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
23
3
-24
-4
12
0
4
-8
-0
2
Investing Activities
-60
-77
-18
-29
-26
-33
-29
17
52
-17
Operating Activities
144
169
199
65
239
285
21
95
134
225
Financing Activities
-62
-89
-204
-40
-201
-252
12
-119
-186
-205
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
44.53 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
16.97 %
16.61 %
3.24 %
0.73 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
Public / Retail
22.43 %
21.99 %
22.53 %
23.60 %
23.82 %
24.20 %
24.33 %
24.52 %
24.46 %
24.61 %
24.45 %
24.34 %
23.32 %
23.69 %
30.45 %
39.36 %
No of Share Holders
0
47,394
53,304
55,124
56,073
64,012
63,909
62,940
64,422
61,582
60,283
60,761
59,946
58,230
66,741
69,482

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements

Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
5 days ago
Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.
6 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
8 days ago

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,756.85 4,21,527.16 37.86 49,887.20 12.06 9,648 27.34 36.22
Divis Laboratories
5,876.85 1,56,011.90 86.72 8,184.00 0.89 1,600 46.55 47.97
Cipla
1,447.20 1,16,877.90 25.33 26,520.70 14.17 4,155 12.95 38.47
Dr Reddys Laboratories
1,337.20 1,11,577.42 20.90 28,905.40 12.36 5,578 -9.47 52.63
Torrent Pharmaceuticals
3,215.05 1,08,811.90 63.29 10,785.70 11.59 1,656 17.36 36.47
Mankind Pharma
2,596.00 1,07,102.37 52.12 10,615.60 19.57 1,942 28.89 38.60
Zydus Life Science
984.90 99,103.99 23.54 19,831.50 13.82 3,831 14.57 50.66
Lupin
2,128.70 97,110.78 37.44 20,141.50 19.94 1,936 73.53 39.84
Aurobindo Pharma
1,147.55 66,649.89 18.88 29,559.20 17.55 3,169 8.66 30.14
Alkem Laboratories
5,201.50 62,191.73 28.99 12,978.40 9.84 1,812 14.16 33.33

Corporate Action

Technical Indicators

RSI(14)
Neutral
52.26
ATR(14)
Less Volatile
1.14
STOCH(9,6)
Neutral
24.38
STOCH RSI(14)
Neutral
26.40
MACD(12,26)
Bearish
-0.30
ADX(14)
Weak Trend
16.38
UO(9)
Bearish
49.66
ROC(12)
Uptrend And Accelerating
1.99
WillR(14)
Neutral
-56.70
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Intraday Screeners
Candlestick Screeners
Fundamental Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.